Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Liabilities ₹14,925 Cr₹13,309 Cr₹17,566 Cr₹15,397 Cr₹14,069 Cr

What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹14,925 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹14,925 Cr
Mar2024₹13,309 Cr
Mar2023₹17,566 Cr
Mar2022₹15,397 Cr
Mar2021₹14,069 Cr

How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2025 ₹14,925 Cr
12.15
Mar2024 ₹13,309 Cr
-24.23
Mar2023 ₹17,566 Cr
14.08
Mar2022 ₹15,397 Cr
9.44
Mar2021 ₹14,069 Cr -

Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,649.6 Cr 0.6% 7.2% 30.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,631.0 Cr 1.9% -0.8% -3.5% Stock Analytics
DIVIS LABORATORIES ₹175,111.0 Cr 3.2% 4.8% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,228.0 Cr 6.3% 8.9% 15.8% Stock Analytics
CIPLA ₹117,983.0 Cr -3.3% -2% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,782.0 Cr -3.8% -3.1% -8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.6%

7.2%

30.3%

SENSEX

-1.2%

-1.1%

6.3%


You may also like the below Video Courses